Sign Out
FULCOVER capsules are indicated for: Persistent vulvovaginal candidiasis which does not respond to conventional therapy.
Dermatomycosis which does not respond to conventional therapy.
Although proof of efficacy is limited, FULCOVER capsules have been used in fungal keratitis.
Onychomycosis, caused by dermatophytes and/or yeasts and which does not respond to other therapy.
Although proof of efficacy is limited, FULCOVER capsules have been used in: systemic aspergillosis and candidiasis, histoplasmosis, sporotrichosis, paracoccidioidomycosis and blastomycosis.
